SSA
INSM icon

Schonfeld Strategic Advisors’s Insmed INSM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,100
Closed -$1.32M – 2195
2024
Q3 		$1.32M Buy
+18,100
New +$1.34M 0.01% 1060

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schonfeld Strategic Advisors's INSM Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Insmed (INSM) in Q1 2026: 56,056 shares worth $9.17M. The stake represents 0.06% of the portfolio and ranks #322 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in INSM as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in INSM in Q2 2017 and has held it in 20 quarters since. The position peaked at $10M in Q1 2024. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Schonfeld Strategic Advisors held 56,056 shares of Insmed worth $9.17M as of Q1 2026.
  • Insmed was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Insmed made up 0.06% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #322 holding.
  • Schonfeld Strategic Advisors first reported a position in Insmed in Q2 2017 and has held it in 20 quarters since.
  • Schonfeld Strategic Advisors's Insmed position peaked at $10M in Q1 2024.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.